National Guideline Clearinghouse | Therapeutic drug monitoring and pharmacogenetics interface considerations. In: Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice.

Guideline Title
Therapeutic drug monitoring and pharmacogenetics interface considerations. In: Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice.

Bibliographic Source(s)
Shaw L, Burckhart G. Therapeutic drug monitoring and pharmacogenetics interface considerations. In: Valdes R Jr, Payne DA, Linder MW, editor(s). Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice. Washington (DC): National Academy of Clinical Biochemistry (NACB); 2010. p. 29-34. [10 references]

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Therapeutic drug monitoring and pharmacogenetics interface considerations. In: Laboratory medicine practice guidelines: guidelines and recommendations for laboratory analysis and application of pharmacogenetics to clinical practice.